Antibody Information
General Information of This Antibody
Antibody ID | ANI0IJQEE |
|||||
---|---|---|---|---|---|---|
Antibody Name | Anti-CD4 mAb |
|||||
Antibody Type | Monoclonal antibody (mAb) |
|||||
Antibody Subtype | Humanized IgG |
|||||
Antigen Name | T-cell surface glycoprotein CD4 (CD4) |
Antigen Info |
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
CD4-Val-Cit-MMAE [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
18.00 nM
|
Positive CD4 expression (CD4 +++/++) | ||
Method Description |
Receptors (R2) as a function of ADC concentrations, upon incubation with the antibody and following additional 48 h.
|
||||
In Vitro Model | Adult T acute lymphoblastic leukemia | MOLT-4 cells | CVCL_0013 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
22.00 nM
|
Positive CD4 expression (CD4 +++/++) | ||
Method Description |
Receptors (R1) as a function of ADC concentrations, upon incubation with the antibody and following additional 48 h.
|
||||
In Vitro Model | Adult T acute lymphoblastic leukemia | MOLT-4 cells | CVCL_0013 | ||
Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
40.00 nM
|
Positive CD4 expression (CD4 +++/++) | ||
Method Description |
Receptors (R4) as a function of ADC concentrations, upon incubation with the antibody and following additional 48 h.
|
||||
In Vitro Model | Adult T acute lymphoblastic leukemia | MOLT-4 cells | CVCL_0013 |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.